Previous 10 | Next 10 |
Eiger BioPharmaceuticals, Inc. (EIGR) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Sarah Mathieson - SVP, Corporate Affairs David Cory - President & CEO Ingrid Choong - SVP-Clinical Development Eldon Mayer - Chief Commer...
Eiger BioPharmaceuticals press release ( NASDAQ: EIGR ): Q2 GAAP EPS of -$0.51 beats by $0.11 . Revenue of $4.09M (+95.7% Y/Y) misses by $0.99M . For further details see: Eiger BioPharmaceuticals GAAP EPS of -$0.51 beats by $0.11, revenue of $4.09M misses...
Eiger BioPharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update PR Newswire Active Dialogue with FDA on Potential Peginterferon Lambda COVID-19 EUA Application Phase 3 HDV D-LIVR (lonafarnib) Study Topline Data Planned by Yea...
Eiger BioPharmaceuticals to Host Conference Call for Second Quarter 2022 Financial Results and Business Update on Thursday, August 4 PR Newswire - Live Conference Call and Webcast at 4:30 PM ET - PALO ALTO, Calif. , July 28, 2022 /PRNe...
European Commission granted marketing authorization for Zokinvy (lonafarnib) for the treatment of patients with progeria on July 20, 2022. Results from the phase 3 D-LIVR study using Lonafarnib for the treatment of patients with Hepatitis Delta Virus are expected by end of 2022. I...
Eiger BioPharmaceuticals ( NASDAQ: EIGR ) on Wednesday said the European Commission had granted a marketing authorization to its treatment Zokinvy (lonafarnib) for progeria, which is a progressive genetic disorder that causes accelerated aging. The specific indica...
Eiger Receives European Approval for Zokinvy® (lonafarnib) for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies PR Newswire First and only treatment approved in Europe to treat Hutchinson-Gilford progeria syndrome and pro...
Eiger Appoints Senior Human Resources and Organizational Executive Lisa Kelly-Croswell to Board of Directors PR Newswire PALO ALTO, Calif. , July 18, 2022 /PRNewswire/ -- Eiger BioPharmaceuticals , Inc. ( Nasdaq : EIGR ), a commercial-stage biop...
Over the past seven weeks, I have suggested that healthcare stocks, and specifically biopharmaceuticals, had begun to bottom. I expected the process to be rocky with an upside bias. As I spoke with sell side analysts, buy side investors and individuals, I found support for my thinking...
Eiger BioPharmaceuticals Announces Results from Multiple Presentations at the European Association for the Study of the Liver (EASL) International Liver Congress™ 2022 PR Newswire PALO ALTO, Calif. , June 27, 2022 /PRNewswire/ -- Eiger BioPhar...
News, Short Squeeze, Breakout and More Instantly...
Eiger BioPharmaceuticals Inc. Company Name:
EIGR Stock Symbol:
NASDAQ Market:
Eiger BioPharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Nikola Corporation (NKLA) rose 6.5% to $0.95 on volume of 182,734,103 shares WiSA Technologies Inc. (WISA) fell 3.3% to $0.0235 on volume of 160,634,740 shares PROSHARES TRUST (SQQQ) rose 4.7% to $11.12 on volume of 151,373,755 shares...
A look at the top 10 most actives in the United States Sunshine Biopharma Inc. (SBFM) rose 76.0% to $0.1065 on volume of 290,483,542 shares CXApp Inc. (CXAI) rose 151.0% to $6.15 on volume of 236,739,031 shares Nikola Corporation (NKLA) fell 1.0% to $1.03 on volume of 123,276,764 shares ...
Announces “Stalking Horse” Agreement for the Sale of Zokinvy ® (lonafarnib) Patient Access to Zokinvy ® to Continue Uninterrupted PALO ALTO, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR) today ...